查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1788338

全球前哨淋巴结切片市场

Sentinel Node Biopsy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 203 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球前哨淋巴结活检市场规模将达到 13 亿美元

全球前哨淋巴结活检市场规模预计在2024年达到8.293亿美元，预计在2024-2030年的分析期内将以7.1%的复合年增长率增长，到2030年将达到13亿美元。本报告分析的细分市场之一－手术器械，预计其复合年增长率将达到7.9%，到分析期结束时规模将达到7.322亿美元。影像剂细分市场在分析期间内的复合年增长率预计为6.2%。

美国市场规模估计为 2.18 亿美元，中国市场预计复合年增长率为 6.9%

美国哨兵淋巴结切片市场规模预计在2024年达到2.18亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到2.003亿美元，在2024-2030年的分析期内，复合年增长率为6.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为6.7%和5.9%。在欧洲，预计德国市场的复合年增长率为5.6%。

全球前哨淋巴结活检市场—主要趋势和驱动因素摘要

为什么前哨淋巴结切片成为癌症诊断的重要程序？

前哨淋巴结活检 (SNB) 是一种微创外科手术，用于确定癌症的扩散范围，特别适用于乳癌和黑色素瘤。透过识别和分析癌细胞可能到达的第一个淋巴结（前哨淋巴结），SNB 可协助医生评估癌细胞转移情况，而无需进行完整的淋巴结清除术。该技术因其能够减少淋巴水肿等併发症，同时保持较高的诊断准确性，正日益普及。随着全球癌症发生率的上升，以及早期检测在提高存活率方面发挥的关键作用，医疗机构对前哨淋巴结活检的需求日益增长。此外，影像和分子诊断技术的进步也进一步提高了 SNB 的准确性和可靠性。

哪些技术创新正在改进前哨淋巴结活检技术？

放射性追踪剂技术、萤光导引手术和分子影像的最新进展正在彻底改变前哨淋巴结活检。混合示踪剂（结合放射性和萤光染料）的使用提高了检出率，使外科医生能够精确定位前哨淋巴结的位置。人工智慧辅助病理分析进一步提高了切片检查结果的准确性，从而有助于更好地进行癌症分期和製定治疗计划。此外，机器人辅助前哨淋巴结活检正在研究中，以提高准确性并最大限度地减少患者创伤。这些技术突破使前哨淋巴结活检更加高效和准确，使其在肿瘤学实践中的应用日益广泛。

哪些医学领域将推动前哨淋巴结活检的发展？

乳癌诊断仍然是哨兵淋巴结活检的主要应用，而哨兵淋巴结活检 (SNB) 已成为早期乳癌患者的标准治疗方案。皮肤科和肿瘤内科也利用 SNB 进行黑色素瘤分期，准确评估淋巴结转移。头颈癌、妇科癌和前列腺癌领域的新应用正在进一步扩展 SNB 的应用范围。此外，在新兴市场的医疗保健提供者加大对肿瘤学基础设施投资的支持下，他们正在将 SNB 作为改善癌症治疗策略的一部分。

哪些因素推动了前哨淋巴结活检市场的成长？

前哨淋巴结活检市场的成长得益于癌症发病率的上升、微创诊断程序的日益普及以及影像技术的进步。政府推动早期癌症检测和改善肿瘤诊断可近性的措施进一步推动了市场扩张。此外，人工智慧和机器学习在病理学中的应用正在提高前哨淋巴结活检的准确性，从而推动了肿瘤科医生和外科医生的需求。随着精准医疗的不断发展，前哨淋巴结活检有望在个人化癌症治疗和预后诊断中发挥越来越重要的作用。

部分

产品（手术器械、诊断影像、诊断套件）；手术（开放性手术、微创手术）；应用（乳癌、结肠癌、食道癌、其他）；最终用途（医院/诊所、门诊手术中心、诊断中心）

受访公司范例

  • BD（Becton, Dickinson and Company）
  • Boston Scientific Corporation
  • CR Bard, Inc.
  • Cardinal Health
  • Care Wise
  • Devicor Medical Products, Inc.
  • Devicor Medical Products, Inc.
  • Endomagnetics Ltd（Endomag）
  • Gamma Medical Technology
  • Gamma Probe Technologies
  • GE Healthcare
  • Hologic, Inc.
  • Hologic, Inc.
  • Intramedical Imaging LLC
  • IsoRay Medical
  • KUB Technologies Inc.
  • KUB Technologies Inc.
  • LabLogic Systems Ltd（Care Wise）
  • LabLogic Systems Ltd（Care Wise）
  • LymphaTech
  • Medtronic
  • Navidea Biopharmaceuticals, Inc.
  • Philips Healthcare
  • Senti Biosciences
  • Siemens Healthineers
  • Stryker Corporation
  • Stryker Corporation
  • SurgicEye GmbH
  • SurgicEye GmbH
  • Varay Laborix

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP32906

Global Sentinel Node Biopsy Market to Reach US$1.3 Billion by 2030

The global market for Sentinel Node Biopsy estimated at US$829.3 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Surgical Instruments, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$732.2 Million by the end of the analysis period. Growth in the Imaging Agents segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$218.0 Million While China is Forecast to Grow at 6.9% CAGR

The Sentinel Node Biopsy market in the U.S. is estimated at US$218.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$200.3 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Sentinel Node Biopsy Market - Key Trends & Drivers Summarized

Why Is Sentinel Node Biopsy Becoming A Crucial Procedure In Cancer Diagnostics?

Sentinel node biopsy (SNB) is a minimally invasive surgical procedure used to determine the spread of cancer, particularly in cases of breast cancer and melanoma. By identifying and analyzing the first lymph node (sentinel node) that cancer cells are likely to reach, SNB helps physicians assess metastasis without requiring a full lymph node dissection. This technique is gaining popularity due to its ability to reduce complications such as lymphedema while maintaining high diagnostic accuracy. With cancer rates rising globally and early detection playing a critical role in improving survival rates, the demand for sentinel node biopsy procedures is growing across healthcare institutions. Additionally, advancements in imaging and molecular diagnostics are further improving SNB precision and reliability.

What Technological Innovations Are Enhancing Sentinel Node Biopsy Procedures?

Recent advancements in radiotracer technology, fluorescence-guided surgery, and molecular imaging are revolutionizing sentinel node biopsy. The use of hybrid tracers combining radioactive and fluorescent dyes is improving detection rates, allowing surgeons to precisely locate sentinel lymph nodes. AI-assisted pathology analysis is further enhancing the accuracy of biopsy results, leading to better cancer staging and treatment planning. Additionally, robotic-assisted sentinel node biopsies are being explored to improve precision and minimize patient trauma. These technological breakthroughs are making SNB more efficient, accurate, and widely accessible in oncology practices.

Which Medical Sectors Are Driving The Growth Of Sentinel Node Biopsy?

Breast cancer diagnosis remains the leading application of sentinel node biopsy, with SNB becoming the standard of care for early-stage breast cancer patients. Dermatology and oncology practices are also utilizing SNB for melanoma staging, as it allows for precise assessment of lymph node involvement. Emerging applications in head and neck cancer, gynecologic cancers, and prostate cancer are further expanding the use of SNB. Additionally, healthcare providers in emerging markets are adopting SNB as part of improved cancer care strategies, supported by growing investments in oncology infrastructure.

What Factors Are Fueling The Growth Of The Sentinel Node Biopsy Market?

The growth of the sentinel node biopsy market is being driven by increasing cancer prevalence, rising adoption of minimally invasive diagnostic procedures, and advancements in imaging technology. Government initiatives promoting early cancer detection and improved access to oncology diagnostics are further supporting market expansion. Additionally, the integration of AI and machine learning in pathology is enhancing SNB accuracy, driving demand among oncologists and surgeons. As precision medicine continues to evolve, SNB will play an increasingly crucial role in personalized cancer treatment and prognosis.

SCOPE OF STUDY:

The report analyzes the Sentinel Node Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Surgical Instruments, Imaging Agents, Diagnostic Kits); Procedure (Open Surgery, Minimally Invasive Surgery); Application (Breast Cancer, Colon Cancer, Esophageal Cancer, Others); End-Use (Hospitals & Clinics, Ambulatory Surgery Centers, Diagnostic Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 39 Featured) -

  • BD (Becton, Dickinson and Company)
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Cardinal Health
  • Care Wise
  • Devicor Medical Products, Inc.
  • Devicor Medical Products, Inc.
  • Endomagnetics Ltd (Endomag)
  • Gamma Medical Technology
  • Gamma Probe Technologies
  • GE Healthcare
  • Hologic, Inc.
  • Hologic, Inc.
  • Intramedical Imaging LLC
  • IsoRay Medical
  • KUB Technologies Inc.
  • KUB Technologies Inc.
  • LabLogic Systems Ltd (Care Wise)
  • LabLogic Systems Ltd (Care Wise)
  • LymphaTech
  • Medtronic
  • Navidea Biopharmaceuticals, Inc.
  • Philips Healthcare
  • Senti Biosciences
  • Siemens Healthineers
  • Stryker Corporation
  • Stryker Corporation
  • SurgicEye GmbH
  • SurgicEye GmbH
  • Varay Laborix

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Sentinel Node Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Early Cancer Detection Drives Growth in Sentinel Node Biopsy Procedures
    • Surge in Cancer Incidence Rates Expands Market Opportunities for Sentinel Node Biopsy Technologies
    • Technological Advancements in Imaging and Tracers Propel the Accuracy and Effectiveness of Sentinel Node Biopsy
    • Rising Awareness Among Healthcare Providers and Patients of the Benefits of Minimally Invasive Procedures Accelerates Adoption of Sentinel Node Biopsy
    • The Shift Toward Personalized Medicine and Tailored Cancer Treatments Drives Demand for Sentinel Node Biopsy Solutions
    • Increasing Focus on Reducing Surgical Complications and Recovery Times Strengthens the Business Case for Sentinel Node Biopsy
    • Surge in Breast Cancer and Melanoma Cases Drives the Demand for Sentinel Node Biopsy in Oncology Treatments
    • Expansion of Cancer Immunotherapy and Targeted Therapies Fuels Market Growth for Sentinel Node Biopsy Procedures
    • Rising Investment in Advanced Cancer Diagnostics and Staging Technologies Expands Market Potential for Sentinel Node Biopsy
    • Increasing Integration of Artificial Intelligence in Imaging and Diagnostic Technologies Drives Adoption of Sentinel Node Biopsy Solutions
    • Regulatory Support and Approvals for Non-Invasive and Less Invasive Diagnostic Methods Strengthen Demand for Sentinel Node Biopsy Procedures
    • Increasing Preference for Lymph Node Staging Techniques That Minimize Patient Discomfort Drives Adoption of Sentinel Node Biopsy
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sentinel Node Biopsy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Sentinel Node Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Surgical Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostic Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Diagnostic Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Open Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Open Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Minimally Invasive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Colon Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Colon Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Esophageal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • JAPAN
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • CHINA
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • EUROPE
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Sentinel Node Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • FRANCE
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 70: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: France 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • GERMANY
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Germany 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • UNITED KINGDOM
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of World 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030

IV. COMPETITION